Skip to main content

Table 3 Dose differences between CT-based dose calculation and MRI bulk density assigned dose calculation

From: Evaluating organ delineation, dose calculation and daily localization in an open-MRI simulation workflow for prostate cancer patients

 

Plan Max Dose

D99 for Prostate

D95 for Prostate

 

MRI (Gy)

CT (Gy)

MRI (Gy)

CT (Gy)

MRI (Gy)

CT (Gy)

Patient 1

76.61

76.97

72.45

73.70

72.65

73.90

Patient 2

82.43

79.58

77.58

76.05

77.82

76.30

Patient 3

76.17

74.01

70.24

69.78

70.60

70.18

Patient 4

74.81

75.17

70.83

69.10

71.15

70.89

Patient 5

74.25

75.13

70.54

72.01

70.73

72.09

Patient 6

78.02

77.05

73.80

73.76

73.94

73.92

Patient 7

78.78

77.46

73.67

73.42

73.81

73.55

Patient 9

81.59

79.62

76.77

75.77

76.98

75.95

Patient 10

74.97

75.25

70.63

72.03

70.70

72.13

Avg Dose Diff.

−1.01%

−0.11%

0.12%

STDEV

1.69%

−0.34%

−0.09%

P value

0.104

0.816

0.873